Fresenius Kabi & TQ Therapeutics join forces to accelerate cell & gene therapy manufacturing
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Berendsen brings over 15 years of financial leadership experience spanning professional services and international trade
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
CARsgen is working to transform outcomes for patients with solid tumors by advancing the potential of CAR T technologies
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
AbbVie will offer reduced prices for its medicines in Medicaid and commit $100 billion over the next decade to US research, development and capital investments, including domestic manufacturing
Subscribe To Our Newsletter & Stay Updated